创伤性脑损伤硬脑膜破损后病理性高凝状态的血浆代谢组学与蛋白质组学分析
这项前瞻性观察性队列研究纳入2019至2021年在城市一级创伤中心接受神经外科手术的57例成人创伤性脑损伤患者,在硬脑膜破损前和破损后1小时采血,进行柠檬酸化快速血栓弹力图和tPA激发血栓弹力图,并检测组织因子活性、代谢组学和蛋白质组学。结果显示,硬脑膜破损后血凝块最大振幅由63.5 mm升至74.4 mm(p < 0.0001),tPA激发血栓弹力图LY30由2.6%降至1.4%(p = 0.04),组织因子无统计学显著差异。代谢组学显示晚期糖酵解、半胱氨酸和一碳代谢物以及内皮功能障碍/精氨酸代谢/缺氧反应相关代谢物显著增加,蛋白质组学显示血小板活化和纤溶抑制相关蛋白显著增加。作者结论认为,创伤性脑损伤患者存在全身高凝状态,以血凝块强度增加和纤溶减少为特征,并具有独立于组织因子水平的独特代谢组学和蛋白质组学表型。
要点
- 成人创伤性脑损伤患者硬脑膜破损后1小时,血凝块最大振幅由63.5 mm升至74.4 mm(p < 0.0001),提示全身高凝状态。
- 硬脑膜破损后tPA激发血栓弹力图LY30由2.6%降至1.4%(p = 0.04),提示纤溶减少。
- 硬脑膜破损前后组织因子活性无统计学显著差异,高凝状态独立于组织因子水平。
- 代谢组学显示晚期糖酵解、半胱氨酸、一碳代谢及内皮功能障碍/精氨酸代谢/缺氧反应相关代谢物显著增加。
- 蛋白质组学显示血小板活化和纤溶抑制相关蛋白显著增加。
适用人群与场景
- 2019至2021年在城市一级创伤中心接受神经外科手术的成人创伤性脑损伤患者,共57例;61%为男性,中位年龄52岁,70%为钝性创伤,中位格拉斯哥昏迷评分为7分。
研究设计与关键结果
- 前瞻性观察性队列研究,纳入57例接受神经外科手术的成人创伤性脑损伤患者,在硬脑膜破损前和破损后1小时采血。
- 硬脑膜破损后较破损前血凝块最大振幅增加(74.4 mm vs 63.5 mm;p < 0.0001),tPA激发血栓弹力图LY30降低(1.4% vs 2.6%;p = 0.04)。
- 硬脑膜破损前后组织因子活性无统计学显著差异。
- 代谢组学显示晚期糖酵解、半胱氨酸和一碳代谢物以及内皮功能障碍/精氨酸代谢/缺氧反应相关代谢物显著增加。
- 蛋白质组学显示血小板活化和纤溶抑制相关蛋白显著增加。
证据类型、等级与局限
- 证据类型:前瞻性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,创伤性脑损伤患者硬脑膜破损后可出现全身高凝状态,以血凝块强度增加和纤溶减少为特征,并具有独立于组织因子水平的独特代谢组学和蛋白质组学表型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The coagulopathy of traumatic brain injury (TBI) remains poorly understood. Contradictory descriptions highlight the distinction between systemic and local coagulation, with descriptions of systemic hypercoagulability despite intracranial hypocoagulopathy. This perplexing coagulation profile has been hypothesized to be due to tissue factor release. The objective of this study was to assess the coagulation profile of TBI patients undergoing neurosurgical procedures. We hypothesize that dura violation is associated with higher tissue factor and conversion to a hypercoagulable profile and unique metabolomic and proteomic phenotype.
METHODS: This is a prospective, observational cohort study of all adult TBI patients at an urban, Level I trauma center who underwent a neurosurgical procedure from 2019 to 2021. Whole blood samples were collected before and then 1 hour following dura violation. Citrated rapid and tissue plasminogen activator (tPA) thrombelastography (TEG) were performed, in addition to measurement of tissue factory activity, metabolomics, and proteomics.
RESULTS: Overall, 57 patients were included. The majority (61%) were male, the median age was 52 years, 70% presented after blunt trauma, and the median Glasgow Coma Score was 7. Compared with pre-dura violation, post-dura violation blood demonstrated systemic hypercoagulability, with a significant increase in clot strength (maximum amplitude of 74.4 mm vs. 63.5 mm; p < 0.0001) and a significant decrease in fibrinolysis (LY30 on tPAchallenged TEG of 1.4% vs. 2.6%; p = 0.04). There were no statistically significant differences in tissue factor. Metabolomics revealed notable increases in metabolites involved in late glycolysis, cysteine, and one-carbon metabolites, and metabolites involved in endothelial dysfunction/arginine metabolism/responses to hypoxia. Proteomics revealed notable increase in proteins related to platelet activation and fibrinolysis inhibition.
CONCLUSION: A systemic hypercoagulability is observed in TBI patients, characterized by increased clot strength and decreased fibrinolysis and a unique metabolomic and proteomics phenotype independent of tissue factor levels.
参考来源
- Coleman JR, D'Alessandro A, LaCroix I, et al. A metabolomic and proteomic analysis of pathologic hypercoagulability in traumatic brain injury patients after dura violation. J Trauma Acute Care Surg. 2023. PMID: 37405823. doi:10.1097/TA.0000000000004019
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。